LABA/LAMA vs LABA plus inhaled corticosteroid (ICS)
All‐cause death · stable COPD
Long‐acting muscarinic antagonist (LAMA) plus long‐acting… probably leads to higher all‐cause death compared with LABA plus inhaled corticosteroid (ICS) (moderate certainty).
1 finding from 1 review
- Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid… 2023 · Cochrane Headline outcomes onlyOR 1.35 [1.05, 1.75]15 studies · 21510 participantsModerate